Literature DB >> 19380071

Pediatric mitochondrial respiratory chain disorders in the Centro region of Portugal.

Luísa Diogo1, Manuela Grazina, Paula Garcia, Olinda Rebelo, Margarida Alte Veiga, Juan Cuevas, Laura Vilarinho, Isabel Tavares de Almeida, Catarina Resende Oliveira.   

Abstract

The present study reviewed mitochondrial respiratory chain disorders diagnosed at the sole tertiary pediatric hospital in the Centro region of Portugal and estimated incidence and prevalence in this region. The Bernier criteria were used to retrospectively classify 200 children investigated from 1997 to 2006. A total of 78 patients were assigned with definite primary mitochondrial disorder, two thirds presenting in the first year of life. At presentation, 61 children had neuromuscular symptoms. Neurologic, ophthalmologic, growth retardation, muscular, cardiac, respiratory, hepatic, hematologic, and digestive symptoms were the most frequent clinical features. A classic mitochondrial syndrome was identified in 12 children, 6 of them with Leigh syndrome. Major respiratory chain enzymatic defects were detected in 73 cases. Pathogenic mitochondrial DNA or nuclear DNA mutations (or both) were observed in 9 children. Mortality was 29.5%, with median age of death at 8 months. Survival was shorter for patients with onset at infancy or children with liver or cardiac involvement, or with lactic acidosis. Estimated incidence of mitochondrial disorders in children less than 10-years-old was 1.5/10,000, and point prevalence was 5.4/100,000, respectively. These disorders seem to have a high incidence and poor prognosis in the Centro region of Portugal.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19380071     DOI: 10.1016/j.pediatrneurol.2008.11.012

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  6 in total

Review 1.  Therapeutic potential of pyruvate therapy for patients with mitochondrial diseases: a systematic review.

Authors:  Min Li; Shuang Zhou; Chaoyang Chen; Lingyun Ma; Daohuang Luo; Xin Tian; Xiu Dong; Ying Zhou; Yanling Yang; Yimin Cui
Journal:  Ther Adv Endocrinol Metab       Date:  2020-07-09       Impact factor: 3.565

2.  Antenatal manifestations of mitochondrial disorders.

Authors:  Mariana Vide Tavares; Maria João Santos; Ana Patrícia Domingues; João Pratas; Cândida Mendes; Marta Simões; Paulo Moura; Luísa Diogo; Manuela Grazina
Journal:  J Inherit Metab Dis       Date:  2013-01-30       Impact factor: 4.982

3.  Neurofibromatosis Type 1: A Novel NF1 Mutation Associated with Mitochondrial Complex I Deficiency.

Authors:  Sara Domingues; Lara Isidoro; Dalila Rocha; Jorge Sales Marques
Journal:  Case Rep Genet       Date:  2014-03-04

4.  Clinical and molecular characterization of mitochondrial DNA disorders in a group of Argentinian pediatric patients.

Authors:  Mariana Amina Loos; Gimena Gomez; Lía Mayorga; Roberto Horacio Caraballo; Hernán Diego Eiroa; María Gabriela Obregon; Carlos Rugilo; Fabiana Lubieniecki; Ana Lía Taratuto; María Saccoliti; Cristina Noemi Alonso; Hilda Verónica Aráoz
Journal:  Mol Genet Metab Rep       Date:  2021-02-25

5.  The Genetic Landscape of Mitochondrial Diseases in Spain: A Nationwide Call.

Authors:  Marcello Bellusci; Abraham J Paredes-Fuentes; Eduardo Ruiz-Pesini; Beatriz Gómez; Miguel A Martín; Julio Montoya; Rafael Artuch
Journal:  Genes (Basel)       Date:  2021-10-09       Impact factor: 4.096

6.  Cell-permeable succinate prodrugs bypass mitochondrial complex I deficiency.

Authors:  Johannes K Ehinger; Sarah Piel; Rhonan Ford; Michael Karlsson; Fredrik Sjövall; Eleonor Åsander Frostner; Saori Morota; Robert W Taylor; Doug M Turnbull; Clive Cornell; Steven J Moss; Carsten Metzsch; Magnus J Hansson; Hans Fliri; Eskil Elmér
Journal:  Nat Commun       Date:  2016-08-09       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.